Tugce Ulasli - Publications

Early Post-Treatment Eosinophil Elevation and Survival Outcomes in Metastatic Renal Cell Carcinoma Treated with First-Line VEGFR-TKI Monotherapy: A Turkish Multicenter Retrospective Cohort Study.

Journal: Biomedicines

Published: June 22, 2026

Prognostic Significance and Primary-Metastatic Differences in VASH1 Expression, CD34-Defined Microvessel Density, and VEGF Expression in Colorectal Cancer.

Journal: International journal of molecular sciences

Published: June 10, 2026

Elevated B12/CRP Index as a Simple Prognostic Indicator in Patients with Metastatic Renal Cell Carcinoma Treated with First-Line Targeted Therapy.

Journal: Biomedicines

Published: March 03, 2026

Anxiety, depression, and quality of life in metastatic cancer patients receiving immune checkpoint inhibitors: A 2-center cross-sectional study.

Journal: Medicine

Published: January 12, 2026

Baseline serum folic acid as a prognostic biomarker in metastatic renal cell carcinoma treated with targeted therapy.

Journal: Discover oncology

Published: December 05, 2025

Real-world effectiveness and safety of brigatinib in advanced ALK-positive NSCLC: a nationwide multicenter study by the Turkish Oncology Group.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: November 14, 2025

Sleep Quality and Its Determinants Among Patients with Metastatic Cancer Treated with Immune Checkpoint Inhibitors: A Two-Center Cross-Sectional Study.

Journal: Medicina (Kaunas, Lithuania)

Published: October 24, 2025

Prevalence and Characteristics of Sexual Dysfunction in Patients Treated with Immune Checkpoint Inhibitors.

Journal: Medicina (Kaunas, Lithuania)

Published: October 21, 2025

Baseline and three-month De Ritis ratio and gamma-glutamyltransferase as prognostic biomarkers in metastatic renal cell carcinoma treated with targeted therapy.

Journal: Scientific reports

Published: September 30, 2025

Impact of Adipokine Expression on Tumor Characteristics and Survival Outcomes in Patients with Renal Cell Carcinoma.

Journal: Medicina (Kaunas, Lithuania)

Published: July 11, 2025

Early Changes in Volumetric Body Composition Parameters Predict Survival Outcomes in Patients with Metastatic Renal Cell Carcinoma Treated with Targeted Therapy.

Journal: Journal of clinical medicine

Published: March 19, 2025